FDA Inspection
Solara Active Pharma Sciences LimitedSolara Active Pharma Sciences Limited – FDA Inspection, Mar 7, 2020
Record Details
This FDA Inspection record concerns Solara Active Pharma Sciences Limited, with an inspection on March 7, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 7, 2020
- Product Type
- Drugs
View Company Profile
ID · b06c155c-f9f4-4d15-9b1c-575f05bc112a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1123376
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Solara Active Pharma Sciences Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 4, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 5, 2019 | Not classified | Office of Inspections and Investigations | |
| April 21, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 13, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 8, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Solara Active Pharma Sciences Limited
- FDA Inspection 1217304 - 2023-08-04
- FDA Inspection 1100683 - 2019-07-05
- FDA Inspection 1012921 - 2017-04-21
- FDA Inspection 888196 - 2014-06-13
- FDA Inspection 719450 - 2011-04-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.